The CONECTA™ Platform: Integrating Multimodal Foundation Models with Nature’s Chemical Intelligence to Find Solutions for Hard-To-Drug Targets
- Advanced AI is making it possible to discover new oral therapeutics for chronic disease and address significant unmet patient needs
- Montai Therapeutics’ CONECTA™ platform integrates proprietary bioassay data from a diverse chemical space and multimodal foundation models built on billions of chemical and biological datapoints
- This platform enables us to find diverse compounds inspired by nature’s chemical intelligence that can solve previously undruggable targets with the highest probability of becoming successful drugs